Abarelix

Chemical formula: C₇₂H₉₅ClN₁₄O₁₄  Molecular mass: 1,416.09 g/mol  PubChem compound: 16131215

Therapeutic indications

Abarelix is indicated for:

Advanced prostate cancer

Population group: men, only adults (18 years old or older)

Avarelix is indicated for palliative treatment of advanced prostate cancer.

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Get recommendations

Factors such as age, gender, and health history are evaluated to create a personalized medication regimen.

Ask the Reasoner

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.